88 related articles for article (PubMed ID: 310885)
1. Circulating immune complexes in systemic lupus erythematosus. Association with other immunologic abnormalities but not with changes in renal function.
Huston KA; Gupta RC; Donadio JV; McDuffie FC; Ilstrup DM
J Rheumatol; 1978; 5(4):423-32. PubMed ID: 310885
[TBL] [Abstract][Full Text] [Related]
2. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
Davis P; Cumming RH; Verrier-Jones J
Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
[TBL] [Abstract][Full Text] [Related]
3. Specific detection of circulating DNA:anti-DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti-DNA antibody.
Tron F; Letarte J; Roque-Antunes Barreira MC; Lesavre P
Clin Exp Immunol; 1982 Aug; 49(2):481-7. PubMed ID: 6982138
[TBL] [Abstract][Full Text] [Related]
4. [Is the Raji cell test suitable as a marker of systemic lupus erythematosus activity? A case report].
Michel B; Schlumpf U; Fritschy J; Wagenhäuser FJ
Schweiz Med Wochenschr; 1987 Nov; 117(47):1866-74. PubMed ID: 3501164
[TBL] [Abstract][Full Text] [Related]
5. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
6. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
Nguyen CP; Cao VV; Fehér J; Gergely P
Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
[TBL] [Abstract][Full Text] [Related]
7. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
Meryhew NL; Kimberly RP; Messner RP; Runquist OA
J Immunol; 1986 Jul; 137(1):97-102. PubMed ID: 3486919
[TBL] [Abstract][Full Text] [Related]
8. A longitudinal study of circulating immune complexes, dna antibodies and complement in patients with systemic lupus erythematosus: an analysis of their relationship to disease activity.
Harkiss GD; Hazleman BL; Brown DL
J Clin Lab Immunol; 1979 Nov; 2(4):275-83. PubMed ID: 537024
[TBL] [Abstract][Full Text] [Related]
9. Association of anti-DNA idiotype markers with clinical and serological manifestations in patients with systemic lupus erythematosus.
Rauch J; Hazeltine M; Tannenbaum H; Danoff D; Isenberg DA; Wild J; Sampalis J; Esdaile JM
J Rheumatol; 1990 Feb; 17(2):178-85. PubMed ID: 2108245
[TBL] [Abstract][Full Text] [Related]
10. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
11. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
12. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
[TBL] [Abstract][Full Text] [Related]
13. The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis.
Garin EH; Donnelly WH; Shulman ST; Fernandez R; Finton C; Williams RL; Richard GA
Clin Nephrol; 1979 Oct; 12(4):148-55. PubMed ID: 315852
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus.
Jones JV; Cumming RH; Bacon PA; Evers J; Fraser ID; Bothamley J; Tribe CR; Davis P; Hughes GR
Q J Med; 1979 Oct; 48(192):555-76. PubMed ID: 317156
[TBL] [Abstract][Full Text] [Related]
15. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
[TBL] [Abstract][Full Text] [Related]
16. Circulating immune complexes in systemic lupus erythematosus.
Cano PO; Jerry LM; Sladowski JP; Osterland CK
Clin Exp Immunol; 1977 Aug; 29(2):197-204. PubMed ID: 302768
[TBL] [Abstract][Full Text] [Related]
17. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
[TBL] [Abstract][Full Text] [Related]
18. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus.
Siegert C; Daha M; Westedt ML; van der Voort E; Breedveld F
J Rheumatol; 1991 Feb; 18(2):230-4. PubMed ID: 2023216
[TBL] [Abstract][Full Text] [Related]
19. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of circulating immune complex assay in patients with systemic lupus erythematosus.
Phi NC; Chien DK; Chinh DV; Péter G
Acta Med Hung; 1989; 46(2-3):109-20. PubMed ID: 2812955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
